Help I Have a Headache

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the relief of headaches.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to ensure that the packet is intact prior to use; do not administer if the packet is torn, cut, or opened.

The product should be stored at a controlled room temperature, specifically between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). It is essential to protect the product from excessive heat and humidity to maintain its efficacy and safety.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or non-prescription, due to the risk of acetaminophen overdose. Additionally, this product is contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients present in the formulation.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen. Healthcare professionals should advise patients that the risk of liver damage increases under the following circumstances:

• Consumption of more than 12 tablets within a 24-hour period, which is the maximum daily dosage.

• Administration to a child exceeding 5 tablets in a 24-hour period.

• Concurrent use with other medications containing acetaminophen.

• Daily intake of 3 or more alcoholic beverages by an adult while using this product.

In the event of an overdose, which is defined as taking more than the recommended dose, immediate medical assistance is essential. Patients should be instructed to seek medical help or contact a Poison Control Center (1-800-222-1222) without delay, as prompt intervention is critical for both adults and children, even in the absence of noticeable symptoms.

General precautions should be taken prior to use. Patients with a history of liver disease should consult a healthcare provider before using this product. Additionally, individuals taking the anticoagulant warfarin should seek advice from a doctor or pharmacist before use to avoid potential interactions.

Patients should be advised to discontinue use and contact a healthcare professional if any of the following occur:

• Pain worsens or persists for more than 10 days in adults and children.

• Fever intensifies or lasts longer than 3 days.

• New symptoms develop.

• Signs of redness or swelling appear, as these may indicate a serious condition.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly concerning liver health. The product contains acetaminophen, which can lead to severe liver damage under specific circumstances. Notably, patients should not exceed 12 tablets within a 24-hour period, as this is the maximum daily dosage. Additionally, it is critical to monitor the dosage in children, as exceeding 5 tablets in 24 hours can also result in severe liver damage.

The risk of liver damage is further heightened when this product is taken in conjunction with other medications containing acetaminophen or when consumed by adults who regularly consume three or more alcoholic drinks daily.

In the event of an overdose, which is defined as taking more than the recommended dose, patients must seek immediate medical assistance or contact a Poison Control Center. Prompt medical attention is essential for both adults and children, even if no signs or symptoms of overdose are initially apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. Co-administration may lead to an increased risk of acetaminophen-related hepatotoxicity. Monitoring for signs of liver damage is advised in patients who may inadvertently exceed the recommended dosage of acetaminophen.

Packaging & NDC

Below are the non-prescription pack sizes of Help I Have a Headache (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to 11 years may take 1 tablet every 4 to 6 hours as needed, with a maximum of 5 tablets in a 24-hour period unless otherwise directed by a healthcare professional.

For children under 6 years of age, the use of this regular strength product is contraindicated due to the risk of overdose, which may lead to liver damage.

Geriatric Use

Elderly patients should consult a healthcare provider prior to use if they have liver disease, as this may affect the metabolism and clearance of the medication. Additionally, it is important for geriatric patients to seek advice from a doctor or pharmacist if they are concurrently taking warfarin, a blood-thinning medication, due to potential interactions that could increase the risk of bleeding.

In the event of an overdose, prompt medical attention is crucial for elderly patients, as well as for children, even if no immediate signs or symptoms are observed. This underscores the importance of careful monitoring and adherence to prescribed dosages in this population to mitigate risks associated with overdose.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. It is critical to adhere to the recommended dosage guidelines to prevent severe liver damage. The maximum daily amount for adults is 12 tablets within a 24-hour period, while for children, it is limited to 5 tablets in the same timeframe.

Patients with compromised liver function are at an increased risk of liver damage, particularly if they exceed the recommended dosage or if they consume three or more alcoholic drinks daily while using this product. Additionally, caution should be exercised when this product is taken in conjunction with other medications containing acetaminophen, as this may further elevate the risk of severe liver damage.

In the event of an overdose, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay. Prompt medical attention is essential for both adults and children, even if no signs or symptoms of overdose are apparent.

Overdosage

Overdosage may result in significant liver damage, particularly when the recommended dosage is exceeded. It is imperative that healthcare professionals remain vigilant regarding the potential consequences of overdose.

In the event of an overdose, immediate medical assistance should be sought. Healthcare providers are advised to contact a Poison Control Center without delay; the national hotline can be reached at 1-800-222-1222. Prompt intervention is crucial, as the risk of serious complications exists even in the absence of overt signs or symptoms. This applies to both adults and children, underscoring the importance of swift action in all cases of suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or non-prescription. If patients are uncertain about the presence of acetaminophen in their other medications, they should be encouraged to consult with a doctor or pharmacist.

Patients should be cautioned against using this medication if they have a known allergy to acetaminophen or any of the inactive ingredients contained in the product. Additionally, healthcare providers should recommend that patients seek medical advice before using this medication if they have liver disease.

For patients who are taking the blood-thinning medication warfarin, it is essential to advise them to consult with a doctor or pharmacist prior to using this product.

Patients should be instructed to discontinue use and seek medical attention if they experience any of the following: worsening pain or pain that persists for more than 10 days in adults and children; a fever that worsens or lasts for more than 3 days; the emergence of any new symptoms; or the presence of redness or swelling. These symptoms may indicate a serious condition that requires further evaluation.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled room temperature ranging from 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). Care should be taken to avoid exposure to excessive heat and humidity, as these conditions may compromise the integrity of the product.

Additionally, it is crucial to inspect the packaging prior to use. The product should not be utilized if the packet is found to be torn, cut, or opened, as this may indicate contamination or degradation of the product. Proper handling and storage conditions are vital to ensure the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Help I Have a Headache, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)